Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
314,315 The DFS rates of breast cancer patients with 1 or more micrometastatic SLNs 2 mm in the IBCSG 23-01 trial on 10-year follow-up were 74.9% (95% CI: 70.579.3) and 76.8% (95% CI: 72.581.0) for patients that did and did not undergo ALND, respectively (HR: 0.85, 95% CI: 0.651.11
More common but challenging side effects include persistent nausea affecting 44% of users and significant fatigue in 11%
Under-eating and dehydration account for 80%+ of GLP-1 fatigue
Pros: Saxenda can effectively support long-term weight loss and is generally well-tolerated
They had a reduction in HbA1c from 67 to 60 mmol/mol
According to American Diabetes Association guidelines, treatment should be individualized based on patient tolerance, efficacy, and overall benefit-risk profile
US$ 21.11
US$ 22.52
US$ 23.62
US$ 20.92
US$ 27.53
US$ 24.28
